Massachusetts Eye and Ear Infirmary -
243 Charles Street, Boston, MA, 02114 · (617) 523-7900
$347.3M
Net patient revenue, FY 2025
$347.3M
Net patient revenue, FY 2025
Beds
41
FY 2025
Star rating
Not rated
Patient survey: 4 of 5
Net patient revenue
$347.3M
FY 2025
Net income
$12.3M
Patient care margin -31.7%
Discharges
1,553
Occupancy 41.7%
Clinicians
1,012
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
15 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $347.3M | $457.3M | -31.7% | $12.3M | 1,553 | $7.0M | 28.1% | 6.0% |
| 2024 | $311.8M | $432.4M | -38.7% | $1.3M | 1,555 | $5.3M | 25.0% | 8.8% |
| 2023 | $289.3M | $400.8M | -38.5% | -$1.4M | 1,127 | $5.4M | 31.4% | 4.8% |
| 2022 | $263.9M | $359.2M | -36.1% | $2.1M | 1,075 | $4.3M | 33.1% | 6.1% |
| 2021 | $244.6M | $348.5M | -42.5% | $52.5M | 1,033 | $3.9M | 34.6% | 7.8% |
| 2020 | $190.8M | $323.0M | -69.3% | -$11.6M | 1,047 | $4.2M | 44.9% | 5.5% |
Quality of care
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
Death rates
| Hospital-wide death rate within 30 days | 4% | US median 3.9% |
Patient safety
| Serious complications (patient safety composite) | 0.83 | US median 0.96 |
Infections
| C. diff intestinal infections (ratio to expected) | 0.59 | US median 0.28 |
Patient survey
| Doctors always communicated well | 79% | US median 79% |
| Nurses always communicated well | 81% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 50% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 78% | US median 72% |
| Room and bathroom always clean | 75% | US median 73% |
| Patients who would definitely recommend the hospital | 83% | US median 71% |
Timely and effective care
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 174 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 16% | US median 15% |
| Healthcare workers given the flu vaccine | 98% | US median 79% |
Hospital profile
- Medicare certification number (CCN)
- 220075
- Organization NPI
- 1639101751
- Legal name
- Massachusetts Eye and Ear Infirmary
- County
- Suffolk County, MA
- Ownership
- Nonprofit (private)
- Teaching
- Major teaching
- In Medicare since
- 1966
- Full-time employees
- 1,569
- Health system
- Mass General Brigham
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other Mass General Brigham hospitals
| Hospital | Place |
|---|---|
| Massachusetts General Hospital | Boston, MA |
| Brigham and Women's Hospital | Boston, MA |
| McLean Hospital Corporation | Belmont, MA |
| North Shore Medical Center - | Salem, MA |
| Newton-Wellesley Hospital | Newton, MA |
| Brigham and Women Faulkner Hospital | Jamaica Plain, MA |
Other hospitals in Boston
Similar short-term acute care hospitals in Massachusetts
Closest in number of beds
| Hospital | Place | Beds |
|---|---|---|
| Baystate Wing Hospital | Palmer, MA | 46 |
| Baystate Noble Hospital | Westfield, MA | 50 |
| Dana-Farber Cancer Institute | Boston, MA | 30 |
| New England Baptist Hospital | Boston, MA | 62 |
| Beth Israel Deaconess Hospital - Needham | Needham, MA | 73 |
| Falmouth Hospital | Falmouth, MA | 81 |
Medicare hospital stays
Inpatient stays by diagnosis related group (DRG), 2024
| Diagnosis group | Stays | Average charge | Medicare pays per stay | All hospitals |
|---|---|---|---|---|
| DRG 141 MAJOR HEAD AND NECK PROCEDURES WITH CC | 37 | $71,315.57 | $23,710.32 | $19,832.81 |
| DRG 708 MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC | 26 | $40,466.00 | $16,016.27 | $10,548.13 |
| DRG 012 TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH CC | 24 | $110,272.08 | $40,054.67 | $40,955.02 |
| DRG 142 MAJOR HEAD AND NECK PROCEDURES WITHOUT CC/MCC | 18 | $43,331.50 | $17,872.44 | $13,410.42 |
| DRG 144 OTHER EAR, NOSE, MOUTH AND THROAT O.R. PROCEDURES WITH CC | 17 | $54,100.82 | $19,551.24 | $18,331.71 |
| DRG 116 INTRAOCULAR PROCEDURES WITH CC/MCC | 15 | $37,391.93 | $20,157.60 | $17,569.89 |
| DRG 011 TRACHEOSTOMY FOR FACE, MOUTH AND NECK DIAGNOSES OR LARYNGECTOMY WITH MCC | 11 | $119,074.82 | $50,794.09 | $52,600.70 |
| DRG 147 EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC | 11 | $33,836.91 | $14,945.91 | $14,945.91 |
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 3,528 | 2,533 | $1,978.93 | $1,751.67 |
| APC 5492 Level 2 Intraocular Procedures | 1,036 | 935 | $3,451.90 | $3,116.50 |
| APC 5153 Level 3 Airway Endoscopy | 733 | 501 | $1,441.25 | $1,264.08 |
| APC 5503 Level 3 Extraocular, Repair, and Plastic Eye Procedures | 711 | 663 | $1,986.75 | $1,780.31 |
| APC 5165 Level 5 ENT Procedures | 291 | 285 | $5,009.53 | $4,436.36 |
| APC 5154 Level 4 Airway Endoscopy | 262 | 202 | $3,160.90 | $2,832.62 |
| APC 5493 Level 3 Intraocular Procedures | 246 | 208 | $4,471.73 | $4,003.85 |
| APC 5163 Level 3 ENT Procedures | 230 | 116 | $1,292.56 | $1,105.91 |
| APC 5155 Level 5 Airway Endoscopy | 204 | 200 | $5,741.67 | $5,183.46 |
| APC 5504 Level 4 Extraocular, Repair, and Plastic Eye Procedures | 119 | 114 | $3,306.68 | $2,968.58 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 110 | 104 | $2,429.69 | $2,141.49 |
| APC 5164 Level 4 ENT Procedures | 105 | 99 | $2,728.42 | $2,217.17 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. | 5 | $635K |
| Regeneron Pharmaceuticals, Inc. | 12 | $515K |
| Janssen Research & Development, LLC | 28 | $337K |
| Sumitomo Pharma America, Inc. | 36 | $137K |
| Analog Devices Inc. | 1 | $116K |
| KARL STORZ Endoscopy-America | 14 | $99K |
| Cochlear Americas | 10 | $66K |
| Spark Therapeutics, Inc. | 3 | $44K |
| Kyowa Kirin, Inc. | 33 | $42K |
| Inspire Medical Systems, Inc. | 1 | $36K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.